Fennec Pharmaceuticals Inc. (NASDAQ: FENC) stock closed at 8.6 per share at the end of the most recent trading day (a -0.23% change compared to the prior day closing price) with a volume of 97.51K shares and market capitalization of 228.47M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 4 people. Fennec Pharmaceuticals Inc. CEO is Rostislav Raykov.

The one-year performance of Fennec Pharmaceuticals Inc. stock is -11.68%, while year-to-date (YTD) performance is -10.42%. FENC stock has a five-year performance of 28.36%. Its 52-week range is between 6.3 and 10.85, which gives FENC stock a 52-week price range ratio of 50.55%

Fennec Pharmaceuticals Inc. currently has a PE ratio of -12.50, a price-to-book (PB) ratio of 91.91, a price-to-sale (PS) ratio of 660.88, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -81.15%, a ROC of -81.74% and a ROE of -225.12%. The company’s profit margin is -%, its EBITDA margin is -9 566.50%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Fennec Pharmaceuticals Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.11 for the next earnings report. Fennec Pharmaceuticals Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Fennec Pharmaceuticals Inc. is Strong Buy (1), with a target price of $15.67, which is +82.21% compared to the current price. The earnings rating for Fennec Pharmaceuticals Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fennec Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fennec Pharmaceuticals Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.04, ATR14 : 0.42, CCI20 : 79.26, Chaikin Money Flow : 0.02, MACD : 0.38, Money Flow Index : 77.91, ROC : 13.46, RSI : 63.15, STOCH (14,3) : 81.45, STOCH RSI : 0.23, UO : 50.95, Williams %R : -18.55), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fennec Pharmaceuticals Inc. in the last 12-months were: Andrade Robert (Option Exercise at a value of $61 250), Andrade Robert (Sold 25 000 shares of value $223 325 ), Chris A. Rallis (Option Excercise at a value of $14 996), RALLIS CHRIS A (Option Exercise at a value of $5 069), RALLIS CHRIS A (Sold 2 207 shares of value $18 693 )